Background
Elective splenectomy is a surgical treatment for a wide range of diseases, including unexplained splenomegaly, autoimmune, malignant, hereditary, and congenital disorders.
Aim
The aim was to evaluate the outcomes of laparoscopic splenectomy (LS) in different benign splenic disorders.
Materials and methods
This prospective cohort study was conducted on 40 patients prepared for splenectomy in the Gastrointestinal, Liver and Laparoscopic Surgery Unit, General Surgery Department, Tanta University Hospitals, through 2 years. The authors included all patients with age more than 18 years with benign splenic lesions with splene size up to 24 cm. The authors excluded all patients with suspicion of malignancy.
Procedure
LS with posterolateral approach was performed.
Conclusion
LS is a safe procedure in the treatment of benign splenic lesions.